Caseware UK (AP4) 2023.0.135 2023.0.135 2024-01-312024-01-3152023-02-01falseNo description of principal activity0The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falsetruefalse 14590049 2023-01-31 14590049 2023-02-01 2024-01-31 14590049 2022-02-01 2023-01-31 14590049 2024-01-31 14590049 c:Director4 2023-02-01 2024-01-31 14590049 d:CurrentFinancialInstruments 2024-01-31 14590049 d:CurrentFinancialInstruments d:WithinOneYear 2024-01-31 14590049 d:RetainedEarningsAccumulatedLosses 2024-01-31 14590049 c:FRS102 2023-02-01 2024-01-31 14590049 c:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 14590049 c:FullAccounts 2023-02-01 2024-01-31 14590049 c:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 14590049 e:PoundSterling 2023-02-01 2024-01-31 iso4217:GBP xbrli:pure
Company registration number: 14590049







UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 JANUARY 2024


SEL COMMUNITY PHARMACY FED LIMITED






































img6f74.png                        

 


SEL COMMUNITY PHARMACY FED LIMITED
REGISTERED NUMBER:14590049



STATEMENT OF FINANCIAL POSITION
AS AT 31 JANUARY 2024

2024
Note
£

  

Current assets
  

Cash at bank and in hand
  
1,181,640

  
1,181,640

Creditors: amounts falling due within one year
 4 
(1,180,090)

Net current assets
  
 
 
1,550

Total assets less current liabilities
  
1,550

  

Net assets
  
1,550


Capital and reserves
  

Profit and loss account
  
1,550

  
1,550

Page 1

 


SEL COMMUNITY PHARMACY FED LIMITED
REGISTERED NUMBER:14590049


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 JANUARY 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




S A Patel
Director

Date: 13 January 2025

The notes on pages 3 to 4 form part of these financial statements.
Page 2

 


SEL COMMUNITY PHARMACY FED LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2024

1.


General information

SEL Community Pharmacy Fed Limited is a private company, limited by guarantee, registered in England and Wales, company registration number 14590049. The registered office and principal place of business is 1st Floor Office, 89 Station Road, West Wickham, Kent, United Kingdom, BR4 0PX. 
The company was incorporated on 13 January 2023 and this is the first year financial statements. The accounts have been prepared on a 13 month period from 13 January 2023 to 31 January 2024.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. 

 
2.3

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of income and retained earnings in the same period as the related expenditure.

 
2.4

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.


3.


Employees




The average monthly number of employees, including directors, during the period was 5.

Page 3

 


SEL COMMUNITY PHARMACY FED LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2024

4.


Creditors: Amounts falling due within one year

2024
£

Other creditors
202

Accruals and deferred income
1,179,888

1,180,090


 
Page 4